Posted by Michael Wonder on 22 Feb 2018
Federal right-to-try legislation — threatening the FDA’s public health mission
22 February 2018 - A bill passed by the Senate would sharply curtail the FDA’s oversight of access to investigational drugs.
Although its impact would probably be limited, the motivation behind it threatens to weaken the FDA’s ability to pursue its public health mission.
